Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Deborah L. Widomski"'
Autor:
Bryan F. Cox, Steven K. Davidsen, Daniel H. Albert, William T. Noonan, Deborah L. Widomski, Paul Tapang, Gary A. Gintant, Pamela H. Franklin, Ryan M. Fryer, Jason A. Segreti, Patricia N. Banfor, Kelly J. Larson
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 329:928-937
ABT-869 [N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea] is a novel multitargeted inhibitor of the vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) receptor tyrosine kinase family members. AB
Autor:
Bryan F. Cox, James T. Limberis, Gary A. Gintant, Zhi Su, Xiaoqin Liu, Ruth L. Martin, Deborah L. Widomski, Jonathon Green, Gilbert Diaz
Publikováno v:
Biochemical pharmacology. 80(7)
N′1-(3,3,6,8-tetramethyl-1-oxo-1,2,3,4-tetrahydronaphthalen-2-yliden)-2-cyanoethanohydrazide (TTYC) increases secretion of glucagon-like peptide-1 and intracellular Ca 2+ concentration in GLUTag cells. The purpose of the present study was to examin
Autor:
Steven K. Davidsen, Ryan M. Fryer, Pamela A Franklin, Gary A. Gintant, Deborah L. Widomski, Bryan F. Cox, Daniel H. Albert, Jason A. Segreti, Patricia N. Banfor
Publikováno v:
Journal of cardiovascular pharmacology. 53(2)
ABT-869 is a novel multitargeted inhibitor of vascular endothelial growth factor and platelet-derived growth factor receptor tyrosine kinases (RTKs) with potent antiangiogenic properties that slow tumor progression. Vascular endothelial growth factor
Autor:
Glenn A. Reinhart, Deborah L. Widomski, Kristin A. Koch, J. Ruth Wu-Wong, Pamela H. Franklin, Masaki Nakane, Ryan M. Fryer, Bryan F. Cox, Jason A. Segreti, Patricia N. Banfor
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 323(1)
Calcium-sensing receptor (CaR) activation decreases serum parathyroid hormone (PTH) and Ca2+ and, despite long-term reductions in mean arterial blood pressure (MAP), may produce acute hypertension in rats, an effect we hypothesized was mediated by co
Autor:
Tianyuan Zhang, Xiaojun Wang, Bruce A. Beutel, T. Matthew Hansen, Sherry L Carroll, Rongqi Wang, Eric A.G. Blomme, Yi Yang, Hing L. Sham, Yu Gui Gu, Qun Li, Nathan L Lubbers, Moshe Weitzberg, Heidi S. Camp, Jeffrey F. Waring, Deborah L. Widomski, Xiangdong Xu, Richard F. Clark, Christine H Healan-Greenberg, Robert F. Keyes, David W A Beno
Publikováno v:
Journal of medicinal chemistry. 50(5)
A preliminary safety evaluation of ACC2 inhibitor 1-(S) revealed serious neurological and cardiovascular liabilities of this chemotype. A systematic structure-toxicity relationship study identified the alkyne linker as the key motif responsible for t
Autor:
Sofya Tsymbalov, Yan Zhang, Jane R. Connor, Mark G. Currie, Donald W. Hansen, Pamela T. Manning, Linda F. Branson, Clifford R. Dorn, Deborah L. Widomski, William M. Moore, Gina M. Jerome, Barnett S. Pitzele, E. Ann Hallinan
Publikováno v:
Journal of medicinal chemistry. 45(8)
The 5-tetrazole amide of L-N(6)-(1-iminoethyl)lysine (L-NIL), L-N(6)-(1-iminoethyl)lysine 5-tetrazole amide (1), has been prepared and evaluated. In contrast to L-NIL, 1 is a stable, nonhygroscopic, crystalline solid. Unlike L-NIL, 1 has minimal inhi
Autor:
Yu Gui Gu, Moshe Weitzberg, Richard F. Clark, Xiangdong Xu, Qun Li, Nathan L. Lubbers, Yi Yang, David W. A. Beno, Deborah L. Widomski, Tianyuan Zhang, T. Matthew Hansen, Robert F. Keyes, Jeffrey F. Waring, Sherry L. Carroll, Xiaojun Wang, Rongqi Wang, Christine H. Healan-Greenberg, Eric A. Blomme, Bruce A. Beutel, Hing L. Sham
Publikováno v:
Journal of Medicinal Chemistry; Mar2007, Vol. 50 Issue 5, p1078-1082, 5p